Financial Result for June 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Archit Organosys reported its Q1 FY26 results with revenue from operations at Rs. 3,319.56 lakhs, up about 23% from Rs. 2,700.44 lakhs in Q1 FY25. Total income rose to Rs. 3,419.09 lakhs versus Rs. 2,747.03 lakhs a year ago. Net profit more than doubled to Rs. 203.59 lakhs from Rs. 100.54 lakhs, lifting EPS to Rs. 0.99 from Rs. 0.49. Profit before tax came in at Rs. 304.76 lakhs compared with Rs. 141.08 lakhs, with operating profitability improving on better absorption and lower purchase costs. The Board also appointed M/s Ankit Sethi & Associates as Secretarial Auditor for a five-year term starting April 1, 2025, subject to shareholder approval. The statutory auditor (G. K. C & KSI Co.) issued an unmodified limited review report with no qualifications.
Strong double-digit revenue growth and over 100% jump in profit signal a healthy operational quarter, likely to be viewed positively by shareholders. Margin expansion adds to the positive earnings narrative for the stock.